Jpmorgan Chase & CO Recursion Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,176,191 shares of RXRX stock, worth $7.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,176,191

Previous 1,108,727 6.08%

Holding current value

$7.1 Million

Previous $8.32 Million 6.78%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$5.92 - $8.6 $399,386 - $580,190	67,464 Added 6.08%	1,176,191 $7.75 Million
Q2 2024 Aug 12, 2024	BUY	$7.35 - $10.05 $195,671 - $267,551	26,622 Added 2.46%	1,108,727 $8.32 Million
Q1 2024 May 10, 2024	BUY	$9.13 - $15.52 $6.4 Million - $10.9 Million	701,295 Added 184.16%	1,082,105 $10.8 Million
Q4 2023 Feb 12, 2024	SELL	$5.09 - $10.79 $2.92 Million - $6.19 Million	-574,089 Reduced 60.12%	380,810 $3.75 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $3.82 Million - $9.2 Million	580,038 Added 154.73%	954,899 $7.3 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $297,982 - $649,549	65,347 Added 21.11%	374,861 $2.8 Million
Q1 2023 May 18, 2023	BUY	$6.42 - $9.64 $672,103 - $1.01 Million	104,689 Added 51.11%	309,514 $2.06 Million
Q1 2023 May 11, 2023	BUY	$6.42 - $9.64 $202,159 - $303,553	31,489 Added 18.17%	204,825 $1.37 Million
Q4 2022 Feb 13, 2023	SELL	$7.16 - $12.7 $55,862 - $99,085	-7,802 Reduced 4.31%	173,336 $1.34 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $92,300 - $160,316	11,788 Added 6.96%	181,138 $1.93 Million
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.26 $213,247 - $391,799	42,311 Added 33.31%	169,350 $1.38 Million
Q1 2022 May 11, 2022	SELL	$6.16 - $18.03 $181,042 - $529,901	-29,390 Reduced 18.79%	127,039 $910,000
Q4 2021 Feb 10, 2022	BUY	$16.14 - $21.86 $2.01 Million - $2.73 Million	124,826 Added 394.98%	156,429 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $601,405 - $1.31 Million	31,603 New	31,603 $727,000

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.09B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Recursion Pharmaceuticals, Inc. Transaction History